Related Experiment Video
Updated: May 15, 2026

Laparoscopic Oocyte Retrieval and Cryopreservation during Vaginoplasty for Treatment of Mayer-Rokitansky-Kuster-Hauser Syndrome
Published on: May 10, 2022
Therapy with climara in surgical menopause
Daniela Bădoi1, E Crauciuc, Lidia Rusu
1University of Medicine and Pharmacy Grigore T. Popa-Iasi School of Medicine.
Transdermal estradiol therapy effectively treats surgical menopause, improving climacteric symptoms and lipid profiles. This hormone replacement therapy helps prevent adverse effects associated with ovarian hormone deficiency.
Area of Science:
- Gynecology
- Endocrinology
- Cardiovascular Health
Background:
- Surgical menopause results from ovarian hormone loss, necessitating prophylactic measures.
- Hormone replacement therapy (HRT) aims to mitigate short- and long-term effects of ovarian hormone deficiency.
Purpose of the Study:
- To evaluate the efficacy of transdermal estradiol (Climara) in managing surgically induced menopause.
- To assess the impact of transdermal estradiol on lipid profiles and climacteric symptoms.
Main Methods:
- Retrospective study (2004-2006) at a tertiary care hospital.
- Two groups: 46 patients with surgical menopause treated with transdermal estradiol (Climara) and 20 controls not receiving treatment.
Main Results:
- Patients receiving Climara showed decreased total cholesterol, triglycerides, and LDL cholesterol.
- HDL cholesterol levels increased in the Climara group compared to controls.
- Significant improvement in climacteric symptoms was observed in patients treated with transdermal estradiol.
Conclusions:
- Transdermal estradiol therapy (Climara) is an effective treatment for surgically induced menopause.
- This HRT approach positively impacts lipid metabolism and alleviates menopausal symptoms.
Related Concept Videos
Menopause
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Decreased Body Temperature
Factors Affecting Body Temperature
Factors may include:
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
